Proximus Stock Analysis: Dividend Cut, Restructuring and Recovery Prospects
Proximus stock analysis after its dividend cut: assess the 1,200-job restructuring, fibre investment, weak international business and prospects for a cash-flow recovery.
FINANCEMARKETS.INFO
Proximus stock analysis after its dividend cut: assess the 1,200-job restructuring, fibre investment, weak international business and prospects for a cash-flow recovery.
Schneider Electric’s power, cooling and automation technologies make it one of Europe’s leading AI infrastructure investments. But is the stock still attractive near record highs?
Bimzelx generated €1.52 billion in the first half of 2026. Could UCB’s flagship immunology medicine eventually be worth more than €20 billion?
AB InBev has now delivered two consecutive quarters of beer-volume growth, supported by Latin America and strong demand for Corona, Stella Artois and Michelob […]
Sandoz shares rise after Q2 sales grow 9% and biosimilar revenue jumps 22%. Analysis of patent expirations, margins, guidance and regulatory risks.
Novo Nordisk raised its 2026 outlook but shares fell as Wegovy pill sales, CagriSema data and competition from Eli Lilly disappointed investors.
Eli Lilly raises its 2026 revenue outlook after Mounjaro and Zepbound sales soar. Analysis of production, margins, pipeline, Novo Nordisk competition and valuation.
Disney beat profit estimates as streaming income doubled and parks strengthened. We examine revenue, films, TikTok, guidance and valuation.
AMD revenue rose 50% and data-center sales doubled, but its shares fell as margins, guidance and Nvidia competition disappointed investors.
SpaceX revenue jumped 92%, but shares fell as $18.4 billion of capital spending, cash burn and the IPO lock-up worried investors.